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Abstract The role of integrin-mediated adhesion during T cell progenitor homing to and
differentiation within the thymus is ill-defined, mainly due to functional overlap. To circumvent
compensation, we disrupted the hematopoietic integrin regulator kindlin-3 in mice and found a
progressive thymus atrophy that is primarily caused by an impaired homing capacity of T cell
progenitors to the vascularized thymus. Notably, the low shear flow conditions in the vascular
system at midgestation allow kindlin-3-deficient fetal liver-derived T cell progenitors to extravasate
via pharyngeal vessels and colonize the avascular thymus primordium. Once in the thymus, kindlin-3
promotes intrathymic T cell proliferation by facilitating the integrin-dependent crosstalk with
thymic antigen presenting cells, while intrathymic T cell migration, maturation into single positive
CD4 and CD8 T cells and release into the circulation proceed without kindlin-3. Thus, kindlin-3 is
dispensable for integrin-mediated T cell progenitor adhesion and signalling at low and
indispensable at high shear forces.
DOI: https://doi.org/10.7554/eLife.35816.001
Introduction
T cell progenitors develop in the fetal liver (FL) or in the bone marrow (BM) and require the special-
ized environment of the thymus to mature into single positive (SP) CD4 or CD8 T cells (Cai et al.,
2007; Foss et al., 2001; Jotereau et al., 1987). FL-derived T cell progenitors start colonizing the
thymus anlage at around embryonic day (E) 11.5. Since the thymus anlage is initially avascular, T cell
progenitors exit the adjacent pharyngeal vessels, migrate towards the thymic primordium, cross the
dense extracellular matrix of the thymic capsule and finally settle in the thymic tissue. After thymus
vascularization, which occurs at around E15 (Liu et al., 2006), T cell progenitors enter the thymus by
extravasating from post-capillary venules at the cortico-medullary junction. Once in the thymus the
progenitor cells interact and receive signals from thymic epithelial cells, macrophages, dendritic cells
(DCs) and extracellular matrix proteins, which are essential for their proliferation, differentiation,
selection and release into the circulation as mature, single positive T cells (Boehm and Bleul, 2006;
Koch and Radtke, 2011).
Leukocyte extravasation follows a cascade of adhesion events commencing with selectin-medi-
ated rolling of leukocytes on endothelial cells followed by the interaction with endothelial cell-bound
chemokines, integrin-mediated leukocyte arrest and crawling and finally the transmigration through
the vessel wall (Ley et al., 2007). Although integrins are expressed on all hematopoietic cells, con-
flicting reports exist on their role for T cell progenitor extravasation. While the treatment with func-
tion-blocking antibodies against a4 and/or b2 integrins reduced the homing of thymic progenitors
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to the adult thymus (Rossi et al., 2005; Scimone et al., 2006), genetic ablation of neither a4
(Arroyo et al., 1996), nor aL (Schmits et al., 1996), a6 (Georges-Labouesse et al., 1996), b2
(Scharffetter-Kochanek et al., 1998), b7 integrins (Bungartz et al., 2006; Wagner et al., 1996), or
the integrin ligands intercellular adhesion molecule (ICAM) 1 and vascular cell adhesion molecule
(VCAM) 1 (Koni et al., 2001; Sligh et al., 1993; Xu et al., 1994) interfered with thymic coloniza-
tion. Similarly, it is not known whether migration of T cell progenitors within the thymus, or their pro-
liferation and differentiation require integrin-mediated adhesion.
Kindlins are a family of b integrin tail binding proteins that regulate the affinity of integrins for
their ligands and induce signal transduction pathways downstream of activated, ligand-bound integ-
rins (Moser et al., 2009b). Kindlins consist of 3 members: kindlin-1,–2, and  3; while kindlin-1 and
 2 are widely expressed, hematopoietic cells exclusively express kindlin-3 (Ussar et al., 2006;
Weinstein et al., 2003). Consequently, loss of kindlin-3 impairs the functions of all integrins on
hematopoietic cells studied so far and leads to severe defects affecting platelets, leukocytes, osteo-
clasts and hematopoietic stem and progenitor cells (HSPCs) (Kru¨ger et al., 2008; Moser et al.,
2009a; Moser et al., 2008; Ruppert et al., 2015; Schmidt et al., 2011). In line with genetic studies
in mice, loss-of-function mutations in the human KINDLIN-3/FERMT3 gene cause leukocyte adhesion
deficiency type-III (LAD-III) syndrome, which is characterized by severe bleedings, infections and
accumulation of HSPCs in the blood circulation (Kuijpers et al., 2009; Malinin et al., 2009;
Mory et al., 2008; Ruppert et al., 2015; Svensson et al., 2009).
In the present study, we investigated T-lymphopoiesis in kindlin-3-deficient mice. We found that
loss of kindlin-3 protein expression results in progressive thymus atrophy, which is mainly caused by
impaired colonization of the vascularised thymus by BM-derived T cell progenitors during late
embryogenesis and after birth. In contrast, however, colonization of the non-vascularized thymic pri-
mordium by kindlin-3-deficient FL-derived progenitors proceeded without kindlin-3, albeit less effi-
ciently, due to the lower vascular shear flow in embryos. Within the thymus anlage, the proliferation
rate of kindlin-3-deficient T cell populations was reduced, while differentiation into mature CD4 and
CD8 T cells was unaffected. Thus, these findings clearly show the crucial role of integrins during T
cell development. Specifically, in the absence of kindlin-3 only a weak integrin-mediated T cell adhe-
sion can occur, which suffices resistance to low systemic shear forces and enables T cell progenitor
homing early during development. However, at later time points during development, when vascular
shear forces increase, kindlin-3 is critical to stabilize T cell adhesion on endothelial cells allowing T
cell progenitor homing into the thymus.
Results
Loss of kindlin-3 protein leads to progressive thymus atrophy
Kindlin-3 is expressed in CD4/CD8 double negative (DN) and double positive (DP) T cells from wild-
type (WT) thymi and SP CD4 and CD8 T cells from WT spleens (Figure 1—figure supplement 1A).
To test whether kindlin-3 expression is required for thymopoiesis, we investigated thymus morphol-
ogy and size in kindlin-3-deficient (Fermt3-/-) mice, which die of severe bleedings and anemia within
the first week after birth (Moser et al., 2008). The morphology of Fermt3-/- thymi was normal and
the size steadily increased until postnatal day (P) 3 (Figure 1A,B). However, while WT thymi contin-
ued to grow postnatally, Fermt3-/- thymi shrank and became atrophic (Figure 1B). Consistently, the
cellularity of WT thymi continuously increased during development (Figure 1C), while Fermt3-/- thymi
showed an increase in cellularity only until P3, followed by a dramatic decrease at P6 and P8
(Figure 1C). Despite the progressive increase in cellularity until P3 the number of cells was signifi-
cantly lower in Fermt3-/- thymi compared to controls at all time points analyzed (Figure 1C). Impor-
tantly, we did not observe any compensatory expression of kindlin-1 or  2 in kindlin-3-deficient
thymi (Figure 1—figure supplement 1B).
Hematoxylin/eosin (H/E) staining of thymic section at different stages of development revealed a
similar formation of medullary islets in P0 WT and Fermt3-/- thymi that enlarged and fused at P3 to
produce a large central medulla surrounded by the cortex (Figure 1D). In line with the normal thymic
cyto-architecture at P3, Fermt3-/- thymi displayed normal cortico-medullary junctions (CMJ) that sep-
arate CD4/CD8 DP T cells in the cortex from SP CD4 and CD8 T cells in the medulla, and normal epi-
thelial meshes and vascular networks (Figure 1—figure supplement 1C). At P6 and P8, however,
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the atrophic Fermt3-/- thymi showed a progressive enlargement of the medulla and a strong reduc-
tion of the cortex suggesting an imbalanced development towards more mature SP T cells
(Figure 1D). This observation was confirmed by flow cytometry showing that DN T cells containing
the most immature intrathymic T cells were significantly reduced at P3 and P6 in Fermt3-/- thymi
compared to controls. Notably, while the relative distribution of DP and SP CD4 and CD8 T cells
Figure 1. Kindlin-3 deficiency causes thymus atrophy. (A and B) Images from Fermt3+/+ (upper panel) and Fermt3-/- (lower panel) thymi isolated at the
indicated embryonic and postnatal stages. Scale bars 1 mm. (C) Total thymocyte numbers at indicated time points (E14.5 to P8). N(E14.5)=28/28; N
(E16.5)=12/12; N(E18.5)=30/21; N(P3)=6/4; N(P8)=3/2. (D) Haematoxylin and Eosin staining of paraffin-embedded thymus sections. Scale bar 1 mm. (E
and F) Frequencies of CD4 and CD8 double negative (DN), double positive (DP) and single positive CD4 and CD8 thymocytes isolated from P3 and P6
thymi. N(P3)=16/18; N(P6)=8/4. Bars indicate means ± standard errors. **p<0.01; ***p<0.001. See also Figure 1—figure supplement 1.
DOI: https://doi.org/10.7554/eLife.35816.002
The following figure supplement is available for figure 1:
Figure supplement 1. Kindlin-3 deficiency causes thymus atrophy.
DOI: https://doi.org/10.7554/eLife.35816.003
Moretti et al. eLife 2018;7:e35816. DOI: https://doi.org/10.7554/eLife.35816 3 of 28
Research article Developmental Biology Immunology and Inflammation
was still comparable between WT and Fermt3-/- thymi at P3, the relative numbers of DP T cells
decreased and SP CD4 and CD8 T cells increased in P6 thymi of Fermt3-/- mice (Figure 1E,F). How-
ever, despite the shift towards SP T cell populations in P6 Fermt3-/- thymi, their absolute numbers
were still significantly reduced compared to controls (Figure 1—figure supplement 1D,E). The pres-
ence of normal relative SP T cell numbers in Fermt3-/- thymi until P3 suggests that intrathymic T cell
differentiation proceeds independently of kindlin-3. This observation was supported by the normal
levels of T cell receptor (TCR), CD3 and costimulatory molecules such as CD5 and CD24 on DP and
SP T cells (Figure 1—figure supplement 1F).
Thymocyte proliferation depends on kindlin-3 expression
To test whether the number of apoptotic thymocytes is altered within the P3 thymus we immunos-
tained thymic sections for cleaved caspase-3 (Figure 2A) and analysed thymocytes by flow cytometry
after annexin V and 7-AAD (7-Aminoactinomycin) staining (Figure 2B). We found that neither the
number (Figure 2C) nor the frequency (Figure 2D) of apoptotic cells (annexin V+/7-AAD-) was
altered in Fermt3-/- thymi. Furthermore, the different T cell subsets isolated from WT and Fermt3-/-
thymi showed a comparable annexin V staining (Figure 2E).
Next, we determined thymocyte proliferation by in vivo bromodeoxyuridine (BrdU) labelling,
which revealed a significantly reduced number of BrdU positive cells in P3 Fermt3-/- thymi both by
immunohistochemistry (Figure 2F,H) and flow cytometry (Figure 2G,I). Notably, reduced prolifera-
tion was detected in both the DP and the SP T cell populations (Figure 2J). Since thymocyte prolifer-
ation relies on proper contact with antigen presenting cells (APC), we tested kindlin-3-deficient T
cells for their ability to form immune synapses (IS) with WT DCs. To this end we loaded mature DCs
with MOG35-55 peptide and added splenic CD4 T cells from Fermt3+/fl and Fermt3fl/fl mice, which
express a TCR transgene specific for the myelin oligodendrocyte glycoprotein (MOG) 35–55 peptide
(2D2), a double-fluorescent reporter transgene for measuring Cre activity (mTmG) and the CD4-Cre
transgene (Bettelli et al., 2003; Moretti et al., 2013; Muzumdar et al., 2007). After 30 min the
T-DC contacts were analysed by immunofluorescence staining. Although Fermt3-/- T cells formed
fewer contacts with DCs compared to control T cells, recruitment of LFA-1 and actin to the contact
area as well as phospho-Tyrosine signals were indistinguishable between them suggesting that
Fermt3-/- T cells form IS with DCs (Figure 2—figure supplement 1). To study APC-induced T cell
proliferation in vitro, we co-cultured MOG35-55 peptide-loaded dendritic cells with CSFE-labelled
control and kindlin-3-deficient T cells derived from Fermt3fl/fl/CD4-Cre/2D2 mice, and measured
CSFE dilution by flow cytometry. In line with the observation that Fermt3-/- T cells can form contacts
with DCs, a comparable proliferative response was observed when these T cells were stimulated by
DCs loaded with high concentration of MOG35-55 peptide or when a strong TCR signal was induced
directly with anti-CD3/CD28 antibodies. In contrast, Fermt3-/- T cells failed to proliferate when den-
dritic cells were loaded with lower concentrations of MOG35-55 peptide (Figure 2K) indicating that
defective integrin-mediated contact between kindlin-3-deficient T cells and APCs causes a reduced
proliferative response contributing to thymus atrophy of kindlin-3-deficient mice.
T cell progenitor homing to the postnatal thymus
The reduced CD4 and CD8 DN T cell numbers in Fermt3-/- thymi (Figure 1E,F and Figure 1—figure
supplement 1D,E) point to an impaired T cell progenitor homing to the thymus. Upon homing of T
cell progenitors to the thymus, they progress through four DN stages before developing into DP
cells. To test whether loss of kindlin-3 affects the early and/or late stages of DN development, we
separated lineage-positive thymic cells from lineage-negative (Linneg) DN cells by flow cytometry
and gated the latter cell population for high and low CD44 and c-kit expression into DN stage 1 and
2 (DN1-2) and DN stage 3 and 4 (DN3-4) cells, respectively. In parallel, we gated DN cells for high
and low CD44 and CD25 expression to discriminate between the four DN stages. These experiments
revealed that the Linneg DN population was significantly reduced in P3 and P6 thymi and the DN1
and DN2 stage thymocytes were virtually absent from P3 Fermt3-/- thymi (Figure 3A and Figure 3—
figure supplement 1). DN1 stage cells are the immediate intrathymic descendants of circulating
hematopoietic progenitor cells (Linneg, c-kit+, Sca-1- and Sca-1+), which accumulate in the blood cir-
culation of Fermt3-/- mice suggesting that extravasation of Fermt3-/- T cell progenitors is impaired
(Figure 3B,C). To test this hypothesis experimentally, we transferred FL cells from E14.5 WT and
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Figure 2. Reduced thymocyte proliferation contributes to thymus atrophy of kindlin-3-deficient mice. (A) Staining for cleaved caspase-3 counterstained
with Mayer´s haematoxylin on paraffin sections of Fermt3+/+ and Fermt3-/- P3 thymi. Scale bar 100 mm. (B) Single-cell suspensions of thymocytes from
control and Fermt3-/- P3 thymi were stained with the apoptotic (Annexin V) and dead cell (7-AAD) markers. Numbers within the FACS blots represent
percent of cells within each quadrant. (C) Number of apoptotic cells per field of view (fov) observed in (A). N = 10. Percentage of early apoptotic cells
Figure 2 continued on next page
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Fermt3-/- embryos into RAG2-deficient (Rag2-/-) mice, in which T cell development is blocked at the
DN3 stage due to loss of V(D)J rearrangement (Shinkai et al., 1992) and analysed size, weight and
cellularity of the chimeric thymus and T cell frequency in the peripheral blood 8 to 10 weeks later.
The transfer of Fermt3-/- FL cells failed to reconstitute T cell development in the thymus of Rag2-/-
recipient mice (Figure 4A–C), which also contained almost no DN1-2 cells (Figure 4D,E). Interest-
ingly, a very small number of Fermt3-/- T cell progenitors entered the Rag2-/- recipient thymus, differ-
entiated into DN4 cells (Figure 4D,F) and produced a small number of circulating CD4 and CD8 T
cells, which homed to the spleen of Rag2-/- mice (Figure 4G–K) indicating that kindlin-3 is very
important for T cell progenitor homing to the adult thymus, but once in the thymus the progenitor
cells differentiate into mature SP T cells that are released into the circulation.
Since kindlin-3-deficient HSCs show an approximately 5-fold reduced homing capacity to the
bone marrow, which might eventually impact on T cell progenitor generation (Ruppert et al., 2015),
we conditionally deleted Fermt3 by injecting polyIC into Fermt3fl/fl/Mx1-Cre mice and detected
almost no DN (Linneg) cells in their thymi, whereas control thymi from polyIC-treated Fermt3fl/fl mice
clearly contained a discrete population of DN1-2 stage T cells (Figure 4—figure supplement 1A). In
addition, we generated mixed FL cell chimeras by transferring nine times more Fermt3-/- FL cells
than WT FL cells into lethally irradiated recipient mice and compared their homing capacity to the
thymus. To discriminate between both cell populations the WT FL cells were isolated from B6.SJL
embryos, which express the CD45.1 allelic variant, while the Fermt3-/- embryos are from a C57BL/6
background expressing CD45.2. Despite the excess in transferred kindlin-3-deficient FL cells, only
around 25% of the DN cells were of CD45.2 origin. As a control, chimeras made from 90% WT
CD45.2 cells and 10% WT B6.SJL CD45.1 cells showed the 9:1 ratio in DN and all later T cell stages
(Figure 4—figure supplement 1B). Moreover, to exclude a defect in a non-hematopoietic cell type
as cause for the Fermt3-/- T cell progenitor homing defect, we analysed thymi from Kindlin-3-EGFP
knockin mice, which express kindlin-3 tagged C-terminally with EGFP. Flow cytometry of their thymi
revealed that only CD45+ leukocytes were EGFP-positive and that CD31+ endothelial cells and
EPCAM+ thymic epithelial cells were EGFP negative (Figure 4—figure supplement 2). Altogether,
these experiments show that kindlin-3-deficient T cell progenitors have a strong defect in homing to
the postnatal and adult thymus and that the homing defect is of hematopoietic origin.
T cell progenitor homing to the thymus primordium
Since thymi of newborn Fermt3-/- mice lacked DN1 and DN2 cells but contained DN3 and DN4 cells
(Figure 3A) we surmised that during development significant numbers of T cell progenitors from the
FL must be able to colonize the fetal thymus. To test this hypothesis, we determined numbers and
locations of CD45+ hematopoietic progenitor cells in sections of the thymus primordium at different
time points. In line with previous reports (Douagi et al., 2000; Itoi et al., 2001), we observed the first
wave of WT CD45+ progenitor cells within the perithymic mesenchyme at E11.5, and initial migration
into the thymus primordium at E12.0 and scattering throughout the thymus at E12.5 and E13.5
(Figure 5A–F). Interestingly, also Fermt3-/- progenitor cells could be detected in the thymus primor-
dium and the surrounding mesenchyme, however at lower numbers (Figure 5A–E). Despite the reduc-
tion, CD45+ progenitor cells accumulated at E13.5 in the Fermt3-/- thymus (Figure 5D) and continued
Figure 2 continued
(Annexin V+, 7-AAD-) in control and Fermt3-/- thymi (D) and in distinct T cell subpopulations (CD4/CD8 DN, CD4/CD8 DP, CD4 single positive and CD8
single positive) (E). N = 7/10. (F) Sections of Fermt3+/+ and Fermt3-/- P3 thymi stained for BrdU incorporation and counterstained with Mayer´s
haematoxylin. Scale bar 100 mm. (G) BrdU incorporation in thymocytes analysed by flow cytometry. (H) Numbers of BrdU positive cells per field of view
(fov) observed in (F). N = 8/6. (I) Percentage of proliferating, BrdU positive thymocytes measured by flow cytometry. N = 14. (J) Percentage of BrdU
positive cells in distinct T cell subpopulations. N = 14. (K) CD4 T cells isolated from spleens of control Fermt3fl/fl/2D2 and Fermt3fl/fl/2D2/CD4Cre mice
were stained with CFSE and stimulated either with DCs loaded with different concentrations of MOG35-55 peptide or primed with anti-CD3e/CD28
antibodies and PMA. Representative histograms show CSFE dilution. Red-lined histograms represent cells incubated with not-loaded DCs or no
antibodies. Bars indicate means ± standard errors. **p<0.01; ***p<0.001. See also Figure 2—figure supplement 1.
DOI: https://doi.org/10.7554/eLife.35816.004
The following figure supplement is available for figure 2:
Figure supplement 1. Reduced thymocyte proliferation contributes to thymus atrophy of kindlin-3-deficient mice.
DOI: https://doi.org/10.7554/eLife.35816.005
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developing into DN1-2 cells (Figure 5F). Strikingly, a dramatic drop in the DN1-2 population was
observed in Fermt3-/- thymi at E15-16 (Figure 5G,H and Figure 5—figure supplement 1A,B).
Next we tested whether an abnormal Fermt3-/- progenitor cell development in the FL or release
from the FL into the circulation caused the reduced colonization of the thymus primordium. The flow
cytometric analyses revealed that the absolute numbers of Linneg, c-kithi, CD45+, PIR+ T cell progeni-
tors were comparable between WT and Fermt3-/- FLs, while their frequency, due to a decreased cel-
lularity of Fermt3-/- FLs, was increased (Figure 6A–C). The numbers of circulating WT and Fermt3-/-
Linneg, c-kithi, PIR+ T cell progenitors increased between E11.5 to E12. However, while the frequency
Figure 3. Reduced frequencies of T cell progenitors in Fermt3-/- thymi. (A) Thymocytes from Fermt3+/+ and Fermt3-/- mice were stained for lineage
markers (B220, CD19, TER119, NK1.1, CD11b, Gr-1, CD8a, CD3e, TCRb, TCRgd and CD11c), CD44 and c-kit to identify DN1-2 (Lin
neg, c-kithi, CD44hi) and
the DN3-4 (Lin
neg, c-kitlow, CD44low) populations. (B and C) PB from Fermt3+/+ and Fermt3-/- animals (P3) were stained for lineage markers (TER119,
B220, CD11b, Gr-1, CD11c, NK1.1, CD4 and CD8a), c-kit and Sca-1 to identify hematopoietic progenitor cells and analysed by flow cytometry. N = 4.
Numbers within the representative FACS plots indicate cell percentages. Bars indicate means ± standard errors. **p<0.01; ***p<0.001. See also
Figure 3—figure supplement 1.
DOI: https://doi.org/10.7554/eLife.35816.006
The following figure supplement is available for figure 3:
Figure supplement 1. Reduced frequencies of T cell prognitors in Fermt3-/- thymi.
DOI: https://doi.org/10.7554/eLife.35816.007
Moretti et al. eLife 2018;7:e35816. DOI: https://doi.org/10.7554/eLife.35816 7 of 28
Research article Developmental Biology Immunology and Inflammation
of WT T cell progenitors steadily decreased between E12 and E13.5, the T cell progenitors accumu-
lated in the circulation of Fermt3-/- fetuses due to their reduced extravasation from pharyngeal ves-
sels and/or impaired migration towards the thymus primordium (Figure 6D,E).
T cell progenitor homing to the thymus is directed by chemokine gradients produced by thymic
epithelial cells (Koch and Radtke, 2011). Therefore, we decided to test whether Fermt3-/- progeni-
tors are able to sense the chemokine gradient released by thymic lobes in vitro and to invade the
thymus. To this end, thymic lobes from WT E15.5 SJL embryos (CD45.1+) were depleted from their
Figure 4. Kindlin-3-deficient T cell progenitors are severely impaired in seeding the adult thymus. (A–C) Images (A), weights (B) and cell numbers (C) of
thymi from adult WT and Rag2-/- mice and Rag2-/- mice 10 weeks after reconstitution with Fermt3+/+ and Fermt3-/- fetal liver cells. Scale bar 5 mm.
N = 10. (D) Single-cell suspensions were stained for lineage markers (B220, CD19, TER119, NK1.1, CD11b, Gr-1, CD11c, CD8a, CD3e, TCRb, and
TCRgd), c-kit, CD44 and CD25 to identify the DN1-2 (Lin
neg, c-kithi, CD44hi) and the DN3-4 (Lin
neg, c-kitlow, CD44low) populations (upper panel), and DN1
(Linneg, CD44hi, CD25-), DN2 (Linneg, CD44hi, CD25+), DN3 (Linneg, CD44low, CD25+) and DN4 (Linneg, CD44low, CD25-) populations (lower panel) by flow
cytometry. Frequencies of DN1-2 (E) and DN4 (F) thymocytes. N = 8–10. (G) Analysis of peripheral blood T-lymphocytes. (H and I) Frequencies of
circulating CD4+ and CD8+ T cells calculated from flow cytometric analyses shown in (G). N = 10. Numbers within the representative FACS plots
indicate cell percentages. (J) Expression of talin-1 and kindlin-3 in CD4+ T cells isolated from the spleen of Rag2-/- mice after reconstitution with
Fermt3+/+ and Fermt3-/- fetal liver cells. GAPDH serves as loading control. (K) genomic PCR of CD8+ T cells sorted from the spleen of Rag2-/-/Fermt3+/+
and Rag2-/-/Fermt3-/- chimeras. Numbers within the representative FACS plots indicate cell percentages. Bars indicate means ± standard errors.
**p<0.01; ***p<0.001. See also Figure 4—figure supplements 1 and 2.
DOI: https://doi.org/10.7554/eLife.35816.008
The following figure supplements are available for figure 4:
Figure supplement 1. Kindlin-3-deficient T cell progenitors are severely impaired in seeding the adult thymus.
DOI: https://doi.org/10.7554/eLife.35816.009
Figure supplement 2. Kindlin-3-deficient T cell progenitors are severely impaired in seeding the adult thymus.
DOI: https://doi.org/10.7554/eLife.35816.010
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T cells with deoxyguanosine (dGuo) and then positioned in a collagen matrix in close proximity to
FL-derived Linneg cells from WT or Fermt3-/- E14.5 C57BL/6 (CD45.2+) embryos (Figure 7A). Progen-
itor migration towards the thymic lobes was monitored for 36 to 48 hr by time-lapse video micros-
copy, which revealed that WT as well as Fermt3-/- FL cells moved persistently towards the thymic
lobes, while migration was not induced when thymic lobes were absent (Figure 7B). To further test
whether FL-derived T cell progenitor cells had invaded the thymus capsule and developed into
mature T cells ex vivo, the lobes were recovered from the collagen matrix and cultured for additional
18 days under conventional fetal thymus organ culture (FTOC) conditions (Figure 7C). Consistent
Figure 5. Kindlin-3-independent colonization of the fetal thymus. (A–D) Sagittal sections of whole embryos at gestational ages E11.5 (A), E12 (B), E12.5
(C) and E13.5 (D) were stained for fibronectin (perithymic mesenchyme, blue), cytokeratin (thymic primordium, green) and CD45 (potential T cell
progenitor cells, red). Scale bars 100 mm. (E) Numbers of CD45+ cells within the thymic primordium and in the perithymic mesenchyme at the indicated
time points. N = 3–4. (F) Representative flow cytometric profiles of fetal thymocytes from control and Fermt3-/- thymi at the indicated time points
stained for lineage markers (B220, CD19, TER119, NK1.1, CD11b, Gr-1, CD11c, CD8a, CD3e, TCRb, and TCRgd), c-kit and CD44 to identify the DN1-2
(Linneg, c-kithi, CD44hi) and the DN3-4 (Lin
neg, c-kitlow, CD44low) populations. Numbers within the representative FACS plots indicate cell percentages.
Frequencies (G) and total number (H) of DN1-2 cells measured in the flow cytometric analyses shown in (F). N = 7–10 Bars indicate means ± standard
errors. *p<0.05; **p<0.01; ***p<0.001. See also Figure 5—figure supplement 1.
DOI: https://doi.org/10.7554/eLife.35816.011
The following figure supplement is available for figure 5:
Figure supplement 1. Kindlin-3-independent colonization of the fetal thymus.
DOI: https://doi.org/10.7554/eLife.35816.012
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Figure 6. Fetal liver-derived T cell progenitors accumulate in the blood. (A) Fetal liver cells from control and Fermt3-/- embryos from indicated
gestational stages were stained for lineage markers (B220, CD19, TER119, NK1.1, Gr-1 and Thy1.2), c-kit, CD45 and PIR and analysed by flow cytometry.
Frequencies (B) and total numbers (C) of PIR+ T cell progenitors per fetal liver. N(E12.5)=7/6; N(E13.5)=8/5; N(E14.5)=10/11; N(E15.5)=4/7. (D) FB from
Fermt3+/+ and Fermt3-/- embryos were stained for lineage markers (B220, CD19, TER119, NK1.1, Gr-1 and Thy1.2), c-kit and PIR and analysed by flow
Figure 6 continued on next page
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with our in vivo data, CD45.2+ Fermt3-/- donor cells normally developed into DP, CD4 and CD8 SP
cells (Figure 7D).
Altogether these findings indicate that Fermt3-/- T cell progenitors normally develop in the FL,
are released into the circulation, sense the chemokine gradient, leave the pharyngeal vessel, albeit
Figure 6 continued
cytometry. (E) Frequencies of circulating PIR+ T cell progenitors determined in (D). N(E11.5)=5; N(E12)=8/3; N(E12.5)=4/5; N(E13.5)=7/6. Numbers within
the representative FACS plots indicate cell percentages. Bars indicate means ± standard errors. *p<0.05; **p<0.01; ***p<0.001.
DOI: https://doi.org/10.7554/eLife.35816.013
Figure 7. Kindlin-3-deficient T cell progenitors home to the fetal thymus and further develop into SP T cells ex vivo. (A) Schematic description of the
thymus attraction experiment. (B) Representative images of the thymus attraction experiment at the beginning and 40 hr after starting the experiment.
Linneg fetal liver cells from control or Fermt3-/- embryos (both CD45.2+) are seen in the upper right corner of the images, a dGuo-treated wild-type fetal
thymus lobe (FT, CD45.1+) is located at the lower left corner. Scale bar 250 mm. (C) Schematic description of the fetal thymus organ culture. (D) dGuo-
treated fetal thymus lobes seeded with fetal liver cells as performed in (B) were further cultured for 18 days. Cells were stained for CD45.1, CD45.2,
CD4, and CD8. Numbers within the representative FACS plots indicate cell percentages.
DOI: https://doi.org/10.7554/eLife.35816.014
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less efficiently than WT T cell progenitors, migrate towards the thymus primordium, invade the thy-
mus capsule and differentiate into different T cell subsets.
Blood flow velocity modulates Fermt3-/- T cell progenitor adhesion to
vascular walls
The differential efficacy of Fermt3-/- T cell progenitor homing to the avascular and vascularized thy-
mus was neither due to different kindlin-3 and talin-1 protein levels in lysates from sorted FL-derived
T progenitor cells (Linneg, c-kit+, PIR+) isolated from E13.5 embryos and DN1 cells (Linneg, CD44+,
CD25-) isolated from P6 thymi nor from an upregulation of talin-1 in Fermt3-/- PIR+ T cell progenitors
(Figure 8A,B). Flow cytometry also excluded differences in surface expression of a4, aL, b1, b2, b3
and b7 integrins on FL-derived T progenitor cells (Linneg, c-kit+, PIR+) (Figure 8—figure supplement
1) and BM-derived LSK cells (Ruppert et al., 2015). Similarly, the CD31-positive vascular network
was indistinguishable in E13.5 and E15.5 thymi from WT and Fermt3-/- mice excluding the possibility
that a potential kindlin-3 expression in endothelial cells (Bialkowska et al., 2010) accounts for the
defective homing to the vascularized thymus (data not shown). Since adhesion and extravasation of
Fermt3-/- T cells can occur on inflamed endothelium expressing high levels of VCAM-1 and ICAM-1
(Manevich-Mendelson et al., 2009; Moretti et al., 2013), we determined the expression of VCAM-
1, ICAM-1 and ICAM-2 by immunostaining and flow cytometry and found them even lower
expressed in pharyngeal vessels compared to intrathymic vessels. Thus this also excludes that an ele-
vated adhesion molecule expression on pharyngeal vessels compared to intrathymic vessels
accounts for the better adhesion and extravasation (Figure 8—figure supplement 2A–E).
Integrin-mediated adhesion of T cells to endothelial adhesion molecules is influenced by the exist-
ing vascular shear stress (Moretti et al., 2013). We therefore hypothesized that Fermt3-/- T cell pro-
genitors show impaired adhesion to the vascular endothelium when blood flow velocity and shear
forces increase during intrauterine development. To test this hypothesis, we injected red fluorescent
microbeads into the yolk-sac vasculature of E12.5 to E16.5 embryos and measured blood flow veloc-
ity by intravital microscopy. We found an increase in blood flow velocity (Figure 8C) and shear rates
(Figure 8D) between E12.5 to 16.5. Accordingly, in vitro flow chamber assays revealed that isolated
T cell progenitors (Linneg, c-kit+, CD45+, Pir+) hardly adhered to P-selectin, CCL21/CCL25 and
ICAM-1 (Figure 8E), while they readily adhered to P-selectin, CCL21/CCL25 and VCAM-1 in a shear
stress-dependent manner. Interestingly, Fermt3-/- T cell progenitors adhered to VCAM-1 but dis-
played a significantly reduced shear force resistance (Figure 8F) suggesting that the increase in
blood flow velocity and shear forces during fetal development prevents Fermt3-/- T cell progenitor
adhesion and extravasation at intrathymic vessels. To demonstrate that a strong reduction in kindlin-
3 expression only allows adhesion of T cells to the vascular surface at sites with lower shear rates, we
adoptively transferred a 1:1 ratio of CSFE and Far Red-labelled CD4 T cells from spleens and LNs of
WT and Fermt3 hypomorphic mice (K3n/-), respectively, into recipient mice and analysed their adhe-
sion to the popliteal LN vasculature by spinning disc confocal microscopy (Figure 8G,H). Fermt3
hypomorphic mice express only 5% kindlin-3 protein and therefore show a strong defect in leukocyte
adhesion (Klapproth et al., 2015). As expected, we observed a reduced number of adherent
Fermt3 hypomorphic T cells in the LN vasculature compared to WT cells (Figure 8H,I). We then
injected fluorescent microspheres and measured the blood flow velocities in LN vessel segments
and determined shear rates adherent cells were exposed to in those vessels. We found that Fermt3
hypomorphic cells adhered preferentially in vessel segments where blood flow velocity and shear
rates were lower compared to WT T cells. The latter adhered to vessel segments with higher blood
flow velocities and shear rates (Figure 8J,K). These findings indicate that kindlin-3 is crucial to stabi-
lize integrin-mediated T cell adhesion to vessel walls exposed to high vascular shear forces.
Discussion
In the present study, we used mice lacking the essential integrin regulatory protein kindlin-3 to
address the role of integrin-mediated adhesion and signalling during T cell progenitor homing to
the thymus and subsequent differentiation within the thymus. We found that in the absence of kind-
lin-3 a well-organized thymus with normal thymus architecture consisting of the four major compart-
ments (subcapsular zone, cortex, medulla and cortico-medullary junction) is initially formed. The
presence and clear separation of DP thymocytes in the cortex from SP CD4 and CD8 T cells in the
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Figure 8. Kindlin-3 is important to stabilize the adhesion of T cell progenitors and mature T cells to vascular integrin ligands when blood flow velocities
and shear rate levels increase during development and in vessel segments of higher blood flow within lymph nodes. (A) Talin and kindlin-3 expression
in FACS-sorted Pir+ T cell progenitor cells from WT FL of E13.5 embryos compared to DN1 cells sorted from the thymus of P6 mice. GAPDH served as
loading control. (B) Talin and kindlin-3 expression in control and kindlin-3-/- Pir+ T cell progenitor cells isolated from E13.5 FL. GAPDH served as loading
control. Mean blood flow velocities (C) and shear rates (D) within the yolk sac vasculature of E12.5 to E16.5 embryos were determined by intravital
microscopy. N = 14/3/8/21/18. (E and F) Relative adhesion of Pir+ T cell progenitor cells FACS-sorted from the FLs of control and Fermt3-/- E13.5
embryos on ICAM-1, P-selectin, CCL21 and CCL25 or on VCAM-1, P-selectin, CCL21 and CCL25 coated ibidi flow chambers with stepwise increasing
shear rates. N  5. Bars indicate means ± standard deviation. (G) Purity of CD4+ T cells from WT and Fermt3 hypomorphic (n/-) mice that have been
labelled with CFSE and Far Red and mixed in a 1:1 ratio. Grey line represents isotype control. (H,I) Adhesion of CD4+ T cells in vivo. (H) Representative
microscopic images of adherent (+/+, red) and (n/-, green) cells in the lymph node vasculature after adoptive transfer. Sum intensity Z projections of
confocal stacks are shown. Segmented lines indicate vessel outlines. Scale bar = 50 mm. (I) Quantification of adherent CD4+ T cells (N = 18–19 vessels
from three mice). (J, K) Microvascular blood flow in the lymph node vasculature. (J) Centerline blood flow velocity and (K) vascular shear rate in LN
Figure 8 continued on next page
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medulla of postnatal thymi indicate that chemokine-driven migration and positioning of developing
T cells to specialized thymic microdomains is not impaired in the absence of kindlin-3 allowing a
well-orchestrated developmental maturation from T cell progenitors to mature T cells. Thus, our
data indicate that chemokine sensing and leukocyte migration within a 3D environment can occur in
the absence of kindlin-3´s role to regulate integrin activity, which is in line with a previous report
(La¨mmermann et al., 2008).
While early thymic development is hardly affected by the lack of kindlin-3, the thymi from kindlin-
3 deficient mice began shrinking after birth. We found two main reasons for the thymic atrophy.
First, kindlin-3-deficient thymocytes exhibited reduced proliferation rates due to a weakened interac-
tion with thymic APCs. A weakened interaction with APCs was also reported for CD4 T cells isolated
from LFA-1 and talin-1 knockout mice to cause reduced T cell proliferation (Graf et al., 2007;
Kandula and Abraham, 2004; Wernimont et al., 2011).
Secondly, we observed a severe T cell progenitor homing defect, which becomes apparent at the
end of embryogenesis. T cell development in the thymus requires a periodic homing of FL or BM-
derived T cell progenitors. The trafficking routes taken by T cell progenitors to the thymus depend
on the vascularisation state of the thymus. After vascularization at E15/E16 (Liu et al., 2006), FL and
later on BM-derived lymphoid progenitors directly enter the thymus at large post-capillary venules
at the thymus cortico-medullary junction. This process is critically dependent on kindlin-3. Further-
more, our findings also show that kindlin-3-dependent adhesiveness through multiple integrin clas-
ses expressed on T lymphoid progenitors is essential for their homing to the vascularized thymus,
while loss of individual integrins either did not or only partially diminish precursor T cell homing
(Scimone et al., 2006).
Our findings also revealed that kindlin-3-deficient T cell progenitors were able to colonize the
non-vascularized thymus primordium and develop into SP CD4 and CD8 T cells that are released
into the circulation and found in the spleen. Although early colonization of the thymus anlage was
slightly delayed and less efficient, kindlin-3-deficient T cell progenitors were capable to leave the
pharyngeal vessels and migrate through the mesenchymal tissue before they reach and enter the
thymic anlage. The reduced homing performance of kindlin-3-deficient T cell progenitors was neither
due to their reduced production in the FL and/or release into the circulation, nor due to a defect in
sensing chemokine cues that direct them towards the thymic primordium. So, we assume that
reduced adhesion to the pharyngeal vessel wall accounts for the mild T cell progenitor homing
defect of kindlin-3-deficient embryos, an assumption, which is also supported by the accumulation of
T cell progenitors in the embryonic circulation.
Why can T cell progenitors extravasate from pharyngeal vessels at early developmental stages
but fail to do so from post-capillary venules at the cortico-medullary junction of the vascularized thy-
mus? We cannot fully exclude that differences in the expression of other cell surface receptors, such
as CD44 or selectin ligands, may exist between FL and BM-derived T cell progenitors, which allow
kindlin-3/integrin independent adhesion and extravasation. However, since impaired adhesion and
extravasation becomes evident already before E16, a time point at which BM-derived T cell progeni-
tors have not formed yet, we do not believe that this can explain the homing defect. The fact that
FL-derived T cell progenitors are initially capable but later fail to home to the thymus suggests that
cell extrinsic rather than cell intrinsic factors are responsible for the impaired colonization. Differen-
ces in thymus vascularization might be an obvious possibility, especially since a previous report
Figure 8 continued
microvessel segments (N = 25–27 field of views from three mice). Bars indicate means ± standard deviation. **p<0.01; ***p<0.001. See also Figure 8—
figure supplements 1 and 2.
DOI: https://doi.org/10.7554/eLife.35816.015
The following figure supplements are available for figure 8:
Figure supplement 1. Kindlin-3 is important to stabilize the adhesion of T cell progenitors and mature T cells to vascular integrin ligands when blood
flow velocities and shear rate levels increase during development and in vessel segments of higher blood flow within lymph nodes.
DOI: https://doi.org/10.7554/eLife.35816.016
Figure supplement 2. Kindlin-3 is important to stabilize the adhesion of T cell progenitors and mature T cells to vascular integrin ligands when blood
flow velocities and shear rate levels increase during development and in vessel segments of higher blood flow within lymph nodes.
DOI: https://doi.org/10.7554/eLife.35816.017
Moretti et al. eLife 2018;7:e35816. DOI: https://doi.org/10.7554/eLife.35816 14 of 28
Research article Developmental Biology Immunology and Inflammation
suggested kindin-3 expression in endothelial cells (Bialkowska et al., 2010). However, we found
normal vascularization of the thymus anlage in the absence of kindlin-3 and could show that thymic
endothelial cells do not express kindlin-3. Since kindlin-3-deficient thymi exhibited a dramatic drop
in the number of DN1 and DN2 cells between E15 to E16, which is the time point when the thymus
becomes vascularized (Liu et al., 2006), we suggest that differences in the adhesive properties of
pharyngeal vs. intrathymic vessels account for this phenomenon. In support of this hypothesis, we
reported that kindlin-3-deficient effector T cells can leave the brain vascular system during inflamma-
tion when the endothelium expresses ICAM-1 and VCAM-1 at high levels (Moretti et al., 2013).
Similarly, kindlin-3-deficient effector T cells cannot extravasate from inflamed dermal microvessels
but are able to leave postcapillary venules of skin-draining inflamed lymph nodes, probably because
the high expression of integrin ligands and P-selectin stabilizes the weak adhesions of kindlin-3-defi-
cient T cells (Cohen et al., 2013). However, expression of the integrin ligands ICAM-1/2 and VCAM-
1 in pharyngeal vessels is lower than in intrathymic vessels thereby excluding this possibility. There-
fore, we reasoned that another mechanism must be responsible for the homing ability of kindlin-3-
deficient T cell progenitors to the early thymus.
Beside its role in triggering integrin activation in association with talin-1 (Ma et al., 2008;
Montanez et al., 2008; Moser et al., 2009a; Moser et al., 2009b; Moser et al., 2008), kindlin-3 is
important in stabilizing integrin-ligand interactions by promoting integrin clustering (Feng et al.,
2012; Ye et al., 2013). Thus, the gradual T cell progenitor homing defect observed in kindlin-3-defi-
cient mice might be due to instable T cell progenitor/endothelial adhesions, which are unable to with-
stand increasing shear forces elicited by the maturing blood circulation. Using an intravital microscopy
approach we indeed measured an increase in systemic blood flow velocities and shear rates leading to
higher hemodynamic forces T-cell progenitors are exposed to during development. In addition, our
flow chamber experiments with FL-derived T cell progenitors confirmed this as kindlin-3-deficient cells
could adhere to VCAM-1 coated surfaces at low shear stress levels but readily detached at higher
shear stress levels when compared to control cells. Moreover, T cells expressing very low kindin-3 lev-
els predominantly adhere to LN vessel segments with lower shear rates than WT T cells. Thus, low
shear force conditions may allow adhesion of kindlin-3-deficient T cell progenitors to fetal pharyngeal
microvessels, hence enabling their extravasation. However with increasing shear forces at later time
points during fetal life, T cell progenitors lacking kindlin-3 and therefore the ability to strengthening
integrin-mediated adhesion are not able to efficiently adhere to and migrate out of microvessels into
the thymus. The ability to resist low shear forces is also supported by an early report that found high
expression of a4b1 on the surface of FL-derived T cell progenitors (Kawakami et al., 1999). In addi-
tion, we and others have shown that a4b1-mediated adhesiveness to VCAM-1 is less affected by loss
of kindlin-3 in contrast to aLb2 integrin-mediated adhesion to ICAM-1 (Klapproth et al., 2015;Mane-
vich-Mendelson et al., 2009;Moretti et al., 2013). In this respect, it is interesting to note that lack of
b1 integrin expression on hematopoietic stem cells (HSC) abolishes their extravasation and homing to
the BM (Potocnik et al., 2000), whereas kindlin-3-deficient HSCs revealed significantly diminished but
not absent homing to the BM (Ruppert et al., 2015).
Taken together, our work demonstrates that kindlin-3 is dispensable for integrin-mediated T cell
adhesion and signalling at low and indispensable at high vascular shear forces. Furthermore, we also
show a general, crucial role of integrins during T cell development and suggest an additional not yet
investigated T cell phenotype in LADIII patients.
Materials and methods
Key resources table
Reagent type
(species) or resource Designation Source or reference Identifiers Additional information
Genetic reagent
(M.musculus)
Fermt3-/- PMID: 18278053 RRID: MGI:2147790 Dr. Reinhard Fa¨ssler
(Max Planck Institute
of Biochemistry)
Genetic reagent
(M.musculus)
Fermt3flox PMID: 24089451 RRID: MGI:5551978 Dr. Reinhard Fa¨ssler
(Max Planck Institute
of Biochemistry)
Continued on next page
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Reagent type
(species) or resource Designation Source or reference Identifiers Additional information
Genetic reagent
(M.musculus)
Fermt3n/- PMID: 26438512 RRID: MGI:3785479 Dr. Reinhard Fa¨ssler
(Max Planck Institute
of Biochemistry)
Genetic reagent
(M.musculus)
Rag2-/- PMID: 1547487 RRID: MGI:1858556 Dr. Frederick W Alt
(Howard Hughes
Medical Institute)
Genetic reagent
(M.musculus)
Mx1-Cre PMID: 7660125 RRID: MGI:2176073 Dr. Klaus Rajewsky
(Max Delbru¨ck Center
for Molecular Medicine)
Genetic reagent
(M.musculus)
CD4-Cre PMID: 11728338 RRID: MGI: 2386448 Dr. Christopher B.
Wilson, (University
of Washington)
Genetic reagent
(M.musculus)
2D2 PMID: 12732654 RRID: MGI:3700794 Dr. Vijay K Kuchroo
(Center for Neurologic
Diseases)
Genetic reagent
(M.musculus)
mTmG PMID: 17868096 RRID: MGI:3716464 Dr. Liqun Luo
(Howard Hughes
Medical Institute)
Antibody anti-B220-biotin BD Pharmingen Cat. #: 553085;
RRID: AB_394615
FACS (1:200)
Antibody POD-coupled
anti-BrdU
Roche Cat. #: 11 585 860 001;
RRID: AB_514485
IHC (1:30)
Antibody rabbit anti-mouse
cleaved caspase-3
Cell Signalling Cat. #: 9661;
RRID: AB_2341188
IHC (1:100)
Antibody anti-CD3e eBioscience Cat. #: 14-0031-82;
RRID: AB_467049
10 mg/ml
Antibody anti-CD3e-biotin BD Pharmingen Cat. #: 553060;
RRID: AB_394593
FACS (1:200)
Antibody anti-CD3-PE BD Pharmingen Cat. #: 555275;
RRID: AB_395699
FACS (1:200)
Antibody anti-CD4-biotin BD Pharmingen Cat. #: 553649;
RRID: AB_394969
FACS (1:200)
Antibody anti-CD4-FITC BD Pharmingen Cat. #: 553651;
RRID: AB_394971
FACS (1:200)
Antibody anti-CD4-PerCP BD Pharmingen Cat. #: 550954;
RRID: AB_393977
FACS (1:200)
Antibody anti-CD5-PE eBioscience Cat. #: 12-0051-82;
RRID: AB_465523
FACS (1:200)
Antibody anti-CD8a-biotin BD Pharmingen Cat. #: 553028;
RRID: AB_394566
FACS (1:200)
Antibody anti-CD8-APC eBioscience Cat. #: 17-0081-81;
RRID: AB_469334
FACS (1:200)
Antibody anti-CD8-PE eBioscience Cat. #: 12-0081-81;
RRID: AB_465529
FACS (1:200)
Antibody anti-CD11b-biotin BD Pharmingen Cat. #: 557395;
RRID: AB_2296385
FACS (1:200)
Antibody anti-CD11c-biotin BD Pharmingen Cat. #: 553800;
RRID: AB_395059
FACS (1:200)
Antibody anti-CD16/CD32 BD Pharmingen Cat. #: 553142;
RRID:AB_394657
FACS (1:400)
Antibody anti-CD19-biotin eBioscience Cat. #: 13-0193-82;
RRID: AB_657656
FACS (1:200)
Antibody anti-CD24-PE BD Pharmingen Cat. #: 553262;
RRID: AB_394741
FACS (1:200)
Continued on next page
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Reagent type
(species) or resource Designation Source or reference Identifiers Additional information
Antibody anti-CD25-FITC BD Pharmingen Cat. #: 553071;
RRID: AB_394603
FACS (1:200)
Antibody anti-CD28 eBioscience Cat. #: 14-0281-82;
RRID: AB_467190
2 mg/ml
Antibody rat anti-CD31 (PECAM-1) BD Pharmingen Cat. #: 557355;
RRID: AB_396660
IHC (1:300)
Antibody anti-CD31-
Alexa Fluor 647
Biolegend Cat. #: 102415;
RRID: AB_493411
IHC (1:200)
Antibody anti-CD31-eFLour450 eBioscience Cat. #: 48-0311-82;
RRID: AB_10598807
FACS (1:200)
Antibody anti-CD44-PE BD Pharmingen Cat. #: 553134;
RRID: AB_394649
FACS (1:200)
Antibody anti-CD45-FITC eBioscience Cat. #: 14-0451-82;
RRID: AB_467251
IHC (1:100)
Antibody anti-CD45.2-biotin BD Pharmingen Cat. #: 553771;
RRID: AB_395040
FACS (1:200)
Antibody anti-CD45.2-APC eBioscience Cat. #: 17-0454-82;
RRID: AB_469400
FACS (1:200)
Antibody hamster anti-
CD54 (ICAM)
BD Pharmingen Cat. #: 553250;
RRID: AB_394732
IHC (1:100)
Antibody goat anti-
CD106 (VCAM)
R and D Systems Cat. #: AF643;
RRID: AB_355499
IHC (1:80)
Antibody anti-c-kit-APC eBioscience Cat. #: 17-1171-81;
RRID: AB_469429
FACS (1:200)
Antibody anti-c-kit-PerCP Biolegend Cat. #: 105821;
RRID: AB_893230
FACS (1:200)
Antibody mouse anti-pan
-cytokeratin
Sigma-Aldrich Cat. #: C2562;
RRID: AB_476839
IHC (1:400)
Antibody anti-EpCAM-APC
-eFlour780
Thermo Fisher Scientific Cat. #: 47-5791-82;
RRID: AB_2573986
FACS (1:200)
Antibody rat anti-ER-TR4 Eric Vroegindeweij
(Princess Maxima
center of pediatric
oncology)
IHC undiluted
Antibody rat anti-ER-TR5 Eric Vroegindeweij
(Princess Maxima
center of pediatric
oncology)
IHC undiluted
Antibody anti-F4/80-biotin Bio-Rad Cat. #: MCA497GA;
RRID: AB_323806
FACS (1:200)
Antibody alexa-fluor-488-
conjugated anti-
Fluorescin IgG
Thermo Fisher
Scientific
Cat. #: A-11090;
RRID: AB_221562
IHC (1:500)
Antibody rat anti-ICAM-1 PE Biolegend Cat. #:116107;
RRID: AB_313698
FACS (1:200)
Antibody rabbit anti-Fibronectin Merck Millipore Cat. #: AB2033;
RRID: AB_2105702
IHC (1:300)
Antibody mouse anti-GAPDH Merck Millipore Cat. #: CB1001;
RRID: AB_2107426
WB (1:20.000)
Antibody anti-Gr-1-biotin BD Pharmingen Cat. #: 553125;
RRID: AB_394641
FACS (1:200)
Antibody alexa-fluor-546
-conjugated
anti-goat IgG
Thermo Fisher
Scientific
Cat: #: A-11056;
RRID: AB_2534103
IHC (1:300)
Continued on next page
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(species) or resource Designation Source or reference Identifiers Additional information
Antibody alexa-fluor-546-
conjugated
anti-hamster IgG
Thermo Fisher
Scientific
Cat: #: A-21111;
RRID: AB_2535760
IHC (1:300)
Antibody alexa-fluor-546-
conjugated
anti-mouse IgG
Thermo Fisher
Scientific
Cat: #: A-11003;
RRID: AB_2534071
IHC (1:300)
Antibody alexa-fluor-647
-conjugated
anti-mouse IgG
Thermo Fisher
Scientific
Cat: #: A-31571;
RRID: AB_162542
IHC (1:300)
Antibody alexa-fluor-647
-conjugated
anti-rabbit IgG
Thermo Fisher
Scientific
Cat: #: A-21244;
RRID: AB_2535812
IHC (1:300)
Antibody alexa-fluor-488-
conjugated
anti-rat IgG
Thermo Fisher
Scientific
Cat: #: A-11006;
RRID: AB_2534074
IHC (1:300)
Antibody alexa-fluor-647-
conjugated
anti-rat IgG
Thermo Fisher
Scientific
Cat: #: A-21247;
RRID: AB_141778
IHC (1:300)
Antibody anti-Integrin a4-PE BD Pharmingen Cat. #: 553157;
RRID: AB_394670
FACS (1:200)
Antibody anti-Integrin aL-PE BD Pharmingen Cat. #: 553121;
RRID: AB_394637
FACS (1:200)
Antibody anti-Integrin b1-PE Biolegend Cat. #: 102207;
RRID: AB_312884
FACS (1:200)
Antibody anti-Integrin b2-PE BD Pharmingen Cat. #: 553293;
RRID: AB_394762
FACS (1:200)
Antibody anti-Integrin b3-PE eBioscience Cat. #: 12-0611-81;
RRID: AB_465717
FACS (1:200)
Antibody anti-Integrin b7-PE BD Pharmingen Cat. #: 557498;
RRID: AB_396735
FACS (1:200)
Antibody rabbit anti-Kindlin-1 Markus Moser
(MPI of Biochemistry)
WB (1:1000)
Antibody mouse anti-Kindlin-2 Sigma-Aldrich Cat. # SAB4200525
-200UL
WB (1:1000)
Antibody rabbit anti-Kindlin-3 Markus Moser
(MPI of Biochemistry)
WB (1:3000)
Antibody rabbit
anti-pan-laminin
Rupert Timpl IHC (1:700)
Antibody anti-LFA-1-PE BD Pharmingen Cat. #: 553121;
RRID: AB_394637
IF (1:100)
Antibody anti-NK1.1-biotin BD Pharmingen Cat. #: 553163;
RRID: AB_394675
FACS (1:200)
Antibody anti-PIR-APC eBioscience Cat. #: 17-3101-82;
RRID: AB_1944406
FACS (1:200)
Antibody anti-PIR-PE BD Pharmingen Cat. #: 550349;
RRID: AB_393628
FACS (1:200)
Antibody anti-p-Tyrosine Santa Cruz
Biotechnology
Cat. #: sc-7020;
RRID: AB_628123
IF (1:50)
Antibody anti-Sca-1-PE eBioscience Cat. #: 12-5981-82;
RRID: AB_466086
FACS (1:200)
Antibody mouse anti-talin Sigma-Aldrich Cat. #: T3287;
RRID: AB_477572
WB (1:20.000)
Antibody anti-TCRb-PE eBioscience Cat. #: 12-5961-82;
RRID: AB_466066
FACS (1:200)
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Continued
Reagent type
(species) or resource Designation Source or reference Identifiers Additional information
Antibody anti-TCRgd-biotin BD Pharmingen Cat. #: 553176;
RRID: AB_394687
FACS (1:200)
Antibody anti-Ter119-biotin BD Pharmingen Cat. #: 553672;
RRID: AB_394985
FACS (1:200)
Antibody anti-Thy1.2-biotin BD Pharmingen Cat. #: 553001;
RRID: AB_394540
FACS (1:200)
Antibody rat anti-VCAM-1 PE Biolegend Cat. #: 105713;
RRID: AB_1134166
FACS (1:200)
Peptide,
recombinant protein
recombinant
mouse CCL21
R and D Systems Cat. #: 457–6C;
Accession #:
P84444.1
Peptide,
recombinant protein
recombinant
mouse CCL25
R and D Systems Cat. #: 481-TK;
Accession #:
O35903.1
Peptide,
recombinant protein
recombinant
mouse ICAM-1-FC
R and D Systems Cat. #: 796-IC;
Accession #: Q3U8M7
Peptide,
recombinant protein
MOG35-55 MPI of
Biochemistry,
Core facility
Peptide,
recombinant protein
recombinant
mouse P-Selectin-FC
R and D Systems Cat. #: 737-PS;
Accession #:
Q01102
Peptide,
recombinant protein
recombinant
mouse VCAM-1-FC
R and D Systems Cat. #: 643-VM;
Accession #:
CAA47989
Commercial
assay or kit
PE Annexin V
Apoptosis
Detection Kit
BD Biosciences Cat. #: 559763
Commercial
assay or kit
BrdU Flow Kit BD Pharmingen Cat. #: 559619;
RRID: AB_2617060
Commercial
assay or kit
anti-biotin
MicroBeads
Miltenyi Cat. #: 130-090-485;
RRID: AB_244365
Commercial
assay or kit
CD4 T cell isolation
kit
Miltenyi Cat. #: 130-104-454
Commercial
assay or kit
Vectastain Elite ABC
HRP Kit, rabbit IgG
VECTOR
laboratories
Cat. #: PK-6101;
RRID: AB_2336820
Chemical
compound, drug
CellTrace CFSE
Cell Proliferation Kit
Thermo Fisher
Scientific
Cat. #: C34554
Chemical
compound, drug
Collagenase D Sigma-Aldrich Cat. #: C0130 1 mg/ml
Chemical
compound, drug
FITC-Dextran Sigma-Aldrich Cat. #: FD150S
Chemical
compound, drug
DNaseI Sigma-Aldrich Cat. #: D5025 100 U/ml
Chemical
compound, drug
dGuo Sigma-Aldrich Cat. #: D0901 1.35 mM
Chemical
compound, drug
CellTrace Far Red
Cell Proliferation Kit
Thermo Fisher
Scientific
Cat. #: C34564 1 mM
Chemical
compound, drug
FluoSpheres 580/606 Thermo Fisher
Scientific
Cat. #: F8821 1 mM
Chemical
compound, drug
LPS Sigma-Aldrich Cat. #: L2654 1 mg/ml
Chemical
compound, drug
poly-L-Lysine Sigma-Aldrich Cat. #: P8920 pure
Continued on next page
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Continued
Reagent type
(species) or resource Designation Source or reference Identifiers Additional information
Chemical
compound, drug
Phalloidin Alexa350 Thermo Fisher
Scientific
Cat. #: A22281 IF (1:40)
Chemical
compound, drug
PureCol Advanced BioMatrix Cat. #: 5005–100 ML
Chemical
compound, drug
Streptavidin Cy3 Jackson Immuno
Research
Cat. #: 016-160-084;
RRID: AB_2337244
FACS (1:400)
Chemical
compound, drug
Streptavidin FITC Thermo Fisher
Scientific
Cat. #: SA10002 FACS (1:200)
Chemical
compound, drug
Streptavidin PerCP-Cy5.5 BD Pharmingen Cat. #: 551419 FACS (1:200)
Software, algorithm ImageJ National Institute
of Health
RRID:SCR_003070
Software, algorithm ImSpector Pro LaVision
BioTec GmbH
Software, algorithm Photoshop Adobe RRID:SCR_014199
Software, algorithm Slidebook 6.0.8 Software Intelligant
Imaging
Innovations
RRID:SCR_014300
Software, algorithm VirtualDub GNU General
Public License (GPL)
Other Glass Bottom
Microwell Dishes
MatTek Corporation Cat. #: P35G-1.5–20 C
Other Ibidi flow chambers
m-Slide I 0.8 Luer IbiTreat
Ibidi Cat. #: 80196
Mice and chimeras
Fermt3-/- mice have been described previously (Moser et al., 2008). All mice were from a mixed
129/SvJ x C57BL/6 background. FL cell chimeras were generated as previously described
(Pru¨mmer and Fliedner, 1986; Tulunay et al., 1975). Briefly, 5–6  106 cells from the FL of E14.5
embryos were injected into the tail vain of sub-lethally irradiated (1  6 Gy) Rag2-/- mice
(Shinkai et al., 1992) and chimeras were analyzed 8 to 10 weeks later. Mixed FL cell chimeras were
generated by injection of 5  106 E14.5 FL cells from WT or Fermt3-/- embryos, respectively, which
were mixed with E14.5 FL cells from congenic B6.SJL WT embryos in a 9:1 ratio, into lethally irradi-
ated C57BL/6 mice (1  7 Gy and 1  6 Gy with 4 hr in between). Conditional Fermt3 deletion
was obtained upon two intraperitoneal injections of pI-pC (500 mg/mouse) (GE Healthcare) into
Fermt3fl/fl/Mx1-Cre mice. Pictures of dissected thymi were taken with a ProgRes C14 camera
(JenOptic) connected to a Leica MZ FLIII stereomicroscope. All animals were mated and maintained
under specific pathogen-free conditions at the animal facility of the Max Planck Institute of Biochem-
istry. All mouse experiments were performed with the approval of the District Government of
Bavaria.
Western blot analysis
Protein lysates were separated on a 10% SDS-PAGE and analyzed by Western blotting using poly-
clonal rabbit anti-mouse kindlin-1 and kindlin-3 antisera (Ussar et al., 2008; Ussar et al., 2006),
monoclonal mouse anti-kindlin-2 (Sigma), monoclonal mouse anti-talin (Sigma) and mouse anti-
GAPDH monoclonal antibody (Calbiochem) with a LAS-4000 imager (Fujifilm).
Multi-color flow cytometry analysis and cell sorting
Multi-color flow-cytometric analysis and cell sorting were performed using FACS-Calibur and FACS-
Aria flow cytometers (BD Biosciences), respectively. Data for viable cells, which were determined by
forward light scatter and propidium iodide exclusion, were obtained with BD CellQuest Pro soft-
ware. All antibodies we used were purchased from eBioscience or BD Pharmingen. Lineage negative
(Linneg) cell populations were obtained by removal of mature cells using the following cocktails of
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biotinylated antibodies: anti-B220, anti-CD19, anti-TER119, anti-NK1.1, anti-CD11b (Mac-1), anti-Gr-
1, anti-CD8a, anti-CD3e, anti-TCRb, anti-TCRgd and anti-CD11c for fetal and adult thymi; anti-
TER119, anti-B220, anti-CD11b, anti-Gr-1, anti-CD11c, anti-NK1.1, anti-CD4 and-CD8a for postnatal
peripheral blood; anti-B220, anti-CD19, anti-TER119, anti-NK1.1, anti-Gr-1 and anti-Thy1.2 for FL
and fetal blood (FB). Cells were then stained either with PerCP-Cy5.5-conjugated or FITC-coniu-
gated Streptavidin and excluded by FL3 or FL1 FACS channels. The resulting Linneg cell populations
were further gated with anti-CD25-FITC, anti-CD44-PE and anti-c-kit-APC for thymocytes; with anti-
Sca-1-PE and anti-c-kit-APC for postnatal peripheral blood cells; with anti-CD45-FITC, anti-PIR-PE
and anti-c-kit-APC or anti-c-kit-PerCP, anti-PIR-APC and anti-integrin-PE (a4, aL, b1, b2, b3, b7) for
FL cells; with anti-PIR-PE and anti-c-kit-APC for FB cells.
Mature T cells were analyzed for surface receptor expression with anti-CD4-FITC, anti CD8-APC,
anti-CD3-PE, anti-CD5-PE, anti-CD24-PE and TCRb-PE.
FL-Linneg cells used for the time-lapse visualization of thymus attraction (see below) were
obtained by negative selection through MACS separation columns with anti-Biotin-coupled magnetic
beads according to the manufacturer’s instructions (MACS Miltenyi Biotec).
Expression of kindlin-3 in different thymic cell types was analysed by flow cytometry with thymi
from Kindlin-3-EGFP knockin mice. A characterization of this mouse strain expressing a kindlin-3-
EGFP fusion protein will be described elsewhere. In order to analyse kindlin-3 expression in leuko-
cytes, thymic epithelial cells and endothelial cells, an adult thymus or a pool of 5 E15.5 fetal thymi
were squeezed between two glass slides to remove the majority of T cells. The remaining tissue was
digested in 1 mg/ml Collagenase D and 100 U/ml DNase I (both from Sigma) in 3% FCS/PBS for 20
to 30 min at 37˚C, followed by a Fc-receptor block with anti-CD16/CD32 antibody and incubation
with anti-CD31 eFlour450, anti-EpCAM APC eFlour780 (both Invitrogen), anti-CD45.2 APC and anti-
CD3 PE antibodies.
Immunofluorescence analysis of embryos and thymi
4% PFA-prefixed, frozen embryos and thymi embedded in Shandon Cryomatrix compound (Thermo
Scientific) were first sliced into 8–10 mm thick sections and stained with the following antibodies for
the embryos: rabbit anti-fibronectin polyclonal antibody (Chemicon), mouse anti-pan-cytokeratin
monoclonal antibody (Sigma), rat anti-CD45-FITC (eBioscience), goat anti-CD106 (VCAM-1, R & D
Systems), hamster anti-CD54 (ICAM-1, Pharmingen) and rat anti-CD31 (PECAM-1, Pharmingen) fol-
lowed by Alexa-Fluor-647-conjugated anti-rabbit IgG, Alexa-Fluor-546-conjugated anti-mouse IgG,
Alexa-Fluor-488-conjugated anti-rat IgG, Alexa-Fluor-647-conjugated anti-mouse IgG, Alexa-Fluor-
546-conjugated anti-goat IgG, and Fluor-546-conjugated anti-hamster IgG antibodies (Invitrogen);
for the thymus: rabbit anti-pan-laminin polyclonal antibody (gift from Rupert Timpl), mouse anti-pan-
cytokeratin monoclonal antibody (Sigma), rat anti-CD31 (PECAM-1, Pharmingen), rat anti-CD4-FITC
(eBioscience), rat anti-CD8-Biotin (eBioscience), anti-CD106 (VCAM-1, R & D Systems), hamster anti-
CD54 (ICAM-1, Pharmingen), rat anti-ER-TR4 and anti-ER-TR5 polyclonal antibodies (kindly provided
by Eric Vroegindeweij) followed by Alexa-Fluor-647-conjugated anti-rabbit IgG, Alexa-Fluor-647-con-
jugated anti-rat IgG, Alexa-Fluor-488-conjugated anti-Fluorescein/Oregon green IgG, Cy3-coniu-
gated Streptavidin (Jackson), Alexa-Fluor-488-conjugated anti-rat IgG, Fluor-546-conjugated anti-
goat IgG, and Fluor-546-conjugated anti-hamster IgG antibodies (Invitrogen). Thymic sections were
fixed with acetone instead of PFA for anti-ER-TR4 and -TR5 staining.
Relative quantification of ICAM-1 and VCAM-1 expression was performed with directly labelled
antibodies: rat anti-ICAM-1-PE, rat anti-VCAM-1-PE and the respective isotypes, rat anti-CD31-
Alexa-Fluor 647 (all from Biolegend).
The stained sections were mounted with a fluorescence mounting medium (Elvanol) and images
were acquired with a fluorescence microscope (Imager.Z1, Zeiss) and analyzed by the Axio Vision 40
(version 4.8.2.0) software (Zeiss), utilizing 10x, 20x and 40x magnifications.
Immunohistologic analysis of the thymus
4% PFA fixed and paraffin-embedded thymi were sliced into 8 mm tick sections and stained with anti-
bodies. The sections were counterstained with Mayer’s haematoxylin (Merck) and mounted in Entel-
lan (Merck). Haematoxylin and Eosin (H/E) staining was performed according to standard protocol.
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Images were acquired with the light microscope Axioskop (Zeiss) and analyzed with the Adobe Pho-
toshop software.
Apoptosis assays
Paraffin-embedded thymus sections were stained with rabbit anti-mouse cleaved caspase-3 antibody
(Cell Signalling). Apoptotic cells were detected by DAB staining after treatment with the immuno-
peroxidase Vectastain ABC system (Vector Laboratories).
Thymocytes from P3 mice were stained with PE-labeled Annexin V and 7-AAD according to the
manufacturer’s instructions (BD Pharmingen Apoptosis Detection Kit). T cells were additionally
stained for anti-CD4-FITC and anti-CD8-APC and analysed by FACS.
Immune synapse analysis
CD4 T cells were purified from spleen by negative selection using biotinylated anti-CD8, anti-B220,
anti-Gr-1, anti-F4/80 and anti-Ter119 antibodies and anti-biotin microbeads following the manufac-
turer´s instructions (MACS Miltenyi Biotec). Bone marrow derived, LPS matured dendritic cells were
loaded with 1 mg/ml MOG35-55 peptide for 2 hr at a concentration of 106 cell/ml. 1  105 loaded
DCs were mixed with 5  105 CD4 T cells in 200 ml R10 medium and seeded on poly-L-Lysine coated
glass-bottom dishes (Mattek). Cells were fixed after 30 min by adding 200 ml warm 6% PFA in R10
medium for 20 min at 37˚C. After permeabilization with 0.2% Triton X-100 in PBS for 15 min and
blocking with 1% BSA for 1 h cells were stained with antibodies against LFA-1 (clone 2D7, BD Bio-
sciences) and p-Tyrosine (PY199, Santa Cruz Biotechnology). Phalloidin Alexa350 was used to visual-
ize actin. Cells were imaged with a Leica TCS SP5 X confocal microscope (Leica Microsystems)
equipped with a 63  NA 1.40 oil objective and Leica Confocal Software (LAS AF). Single channels
were imaged sequentially. All pictures were processed with Photoshop (Adobe Systems, San Jose´,
California, USA).
Proliferation assays
For in vivo labelling of thymocytes, bromodeoxyuridine (BrdU; 50 mg/gram body weight) was intra-
peritoneally injected into P3 mice. One hour after injection, cells were isolated from thymi and
stained with FITC-labeled anti-BrdU monoclonal antibody (BD Pharmingen BrdU Flow Kit), anti-CD4-
PerCP and anti-CD8-PE antibodies, and analyzed by flow cytometry. Alternatively, paraffin-embed-
ded thymus sections were DAB stained after incubation with a POD-coupled anti-BrdU antibody
(Roche).
For the in vitro labeling of control (WT/2D2) and kindlin-3-deficient (Fermt3-/-/CD4-Cre/2D2)
CD4+ T cells (Moretti et al., 2013), CellTrace CFSE Cell Proliferation Kit (Thermo Fisher) was used
to trace dividing cells. Briefly, single cell suspensions from spleens were treated with ammonium-
chloridepotassium for RBC lysis and CD4 T cells were sorted using CD4 T cell isolation kit (Milteniy
Biotech). T cells were then stained with CFSE according to the manufacturer’s instructions and about
5  104 T cells per sample were cocultured in triplicate in 96-well round bottom plate with 2  104
DCs and increasing concentration of soluble MOG35-55 peptide (0.1, 1 and 10 mg/mL). For T cell
stimulation with anti-CD3e and anti-CD28 Abs, 2  105 CFSE-labelled cells per sample were cultured
in wells pre-coated for 1 hr at 37˚C with anti-CD3e (10 mg/ml, eBioscience), with soluble anti-CD28
(2 mg/ml, eBioscience) and PMA (20 ng/ml). Proliferation was analysed by FACS after 3 days of incu-
bation in R10 (RPMI-1640, 10% FCS, 1x Penicillin-Streptomycin) at 37˚C.
Time-lapse visualization of thymus attraction
Time-lapse imaging of horizontal cell migration to fetal thymus lobes was recorded as previously
described (Liu et al., 2005; Ueno et al., 2005). Briefly, 10 mL of freshly neutralized collagen solution
(1.72 mg/mL PureCol, Advanced BioMatrix, in RPMI 1640-based culture medium) containing 1–2 
105 FL-Linneg cells from either Fermt3+/+ or Fermt3-/- C57BL/6 (CD45.2+) animals was placed in a 35
mm plastic dish and solidified at 37˚C for 10 min. An E15.5 fetal thymus lobe from wild-type SJL
(CD45.1+) mouse, pre-treated for 6 days with 1.35 mM 2-deoxyguanosine (dGuo; Sigma) was posi-
tioned approximately 0.5 mm away from the cell spot. The culture was submerged in 1.72 mg/mL
collagen medium and solidified at 37˚C for 30 min. The dish was placed in 5% CO2 under an Axio-
vert 40 CFL microscope (Zeiss) equipped with a digital CCD camera. The culture was time-lapse
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monitored for 36 to 48 hr. After colonization, fetal thymus lobes were removed from the collagen
gel, rinsed, and further cultured for 18 days under conventional organ culture conditions (see below).
Thymi were than pooled, squeezed through a cell strainer and the resulting single cell suspensions
were stained with anti-CD45.2 to identify FL cell-derived thymocytes and further gated for anti-CD4-
FITC and anti-CD8-APC.
Fetal Thymus Organ Culture
Seeded thymus lobes were cultured on 0.8 mm isopore membrane filters (Millipore) supported by a
Gelfoam sponge (Pfizer) at an interface between 5% CO2-humidified air and RPMI 1640-based cul-
ture medium containing 10% FCS, 100 U/ml penicillin and 100 mg/ml streptomycin (PAA), 2 mM
L-glutamine (PAA), 1X non-essential amino acids (Gibco), 1 mM sodium pyruvate (Gibco), 10 mM
HEPES, 50 mM 2-mercaptoethanol (Sigma). Details have been described (Ueno et al., 2005).
Blood flow velocity measurement
Blood flow velocity measurements were performed in the fetal yolk-sac vasculature of E12.5 to E16.5
fetuses as described (Margraf et al., 2017). Briefly, pregnant WT mice were anesthetised and
fetuses surrounded by the yolk sac and still connected to the placenta were surgically exteriorized
and placed on a modified intravital microscopy stage. Manually prepared glass microcapillaries
(Clark Capillaries GCI150TF-10, Clark Electromedical Instruments, Pangbourne Reading) were used
to inject 4 ml of a 5% FITC dextrane solution (FD150S, Sigma-Aldrich, Taufkirchen, Germany) with 1
ml of red fluorescent microspheres (FluoSpheres polystyrene microspheres 1,0 mm red fluorescent
580/605; Invitrogen) into the fetal vasculature. Imaging was performed using an in vivo microscope
setup (Olympus BX1, Olympus, Hamburg, Germany) equipped with appropriate filter sets and a
double-flash device (Rapp Optoelectronics, Hamburg, Germany). Images were recorded using a 60x
objective (Olympus LUM Plan FI/IR 60x/0.90W) with setup specific CCD-cameras (Kappa CF5 HS;
Kappa Optronics GmbH, Gleichen, Germany, and LaVision Imager ProX pco.1600L, LaVision GmbH,
Goettingen, Germany) and recorded utilizing VirtualDub (www.virtualdub.org) and Imspector Pro
Software (Lavision BioTec GmbH, Bielefeld, Germany). Analysis was performed using ImageJ
(National Institute of Health). Vessel diameters were chosen between 20 and 50 mm.
Flow chamber assays
Flow chamber assays were performed with the ibidi pump system (Martinsried, Germany). Ibidi flow
chambers (m-Slide I 0.8 Luer ibiTreat) were coated with 10 mg/ml recombinant mouse (rm) ICAM-1-
Fc or rmVCAM-1-Fc, 10 mg/ml rmP-selectin-Fc, 5 mg/ml rmCCL21 and 5 mg/ml rmCCL25 (all from R
& D systems) over night at 4˚C. After blocking for 1 hr with 1% casein (Thermo Fisher Scientific) at
room temperature, the channels were filled with control or Fermt3-/- Pir+ T cell progenitors sorted
from E13.5 fetal livers. After 3 min incubation without flow, slow flow of approximately 0.15 dyn/cm2
was applied for 3 min followed by increasing flow of 1 and 3 dyn/cm2 for 10 min each. Pictures were
taken every 5 s for a total of 25 min at an Axiovert 40 CFL microscope (Zeiss) equipped with a digital
CCD camera and a 10 x objective. The number of cells that were adherent immediately before the
start of the fast flow was set to 100%. Cells that did not change position within 10 s were considered
to be firmly adherent.
Live cell imaging of T cell adhesion within the lymph node vasculature
and flow in vivo
CD4 T cells were isolated from spleen by negative selection as described above. Anaesthetized mice
were injected intravenously with a 1:1 mixture of CFSE and Far Red labelled WT and Fermt3 hypo-
morphic CD4 T cells. The hair of the hind legs was removed and mice were placed into an imaging
chamber with integrated heating plate. In a dorsal approach the skin of the hind legs was cut and
the popliteal lymph nodes were exposed. To reveal the superficial vessels of the lymph nodes, they
were fixed to the biceps femoris muscle using Histoacryl tissue adhesive (B. Braun). PBS-soaked bat-
ting was placed around the legs to keep the tissue moist. The lymph nodes were covered with a
cover glass, which was topped with PBS to facilitate imaging. Time-lapse video microscopy was per-
formed using an upright spinning disk confocal microscope (Examiner, Zeiss, Germany) equipped
with a confocal scanner unit CSU-X1 (Yokogawa Electric Corporation, Japan), an EMCCD camera
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(Evolve, Photometrics, USA) and a 20x/1.0NA water immersion objective (Zeiss, Germany). 4D
images (30 z-stacks with a step size of 4 mm and an average time lapse interval of 42 s) were
acquired by using two lasers with an excitation wavelength of 488 nm and 640 nm. Adhesion was
analyzed by generating sum projections of z-stacks over time using Slidebook 6.0.8 Software (3i,
USA). The number of adherent leukocytes was determined as cells attached to the same position for
more than 1 min using Fiji/ImageJ software (NIH, USA). Centerline blood flow velocities in the same
vessels were obtained upon subsequent intravenous injection of 107 fluorescent microspheres (1 mm
in diameter; FluoSpheres 580/605, Invitrogen) by measuring frame-to-frame displacement of single
beads in LN microvessel segments. Images of one plane with an average time lapse interval of 66.5
ms were acquired for one minute using one laser with an excitation wavelength of 561 nm. Wall
shear rates were calculated as previously described (Sperandio et al., 2006).
Statistic analysis
Means, standard deviations and statistical comparisons with Student’s t-test (*p<0.05, **p<0.01,
***p<0.001) were made using Microsoft Excel software.
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